Correction: PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy.

[This corrects the article DOI: 10.18632/oncotarget.16028.

PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy.

Recurrent pregnancy loss (RPL) affects 2-3% of couples. Despite a detailed work-up, the etiology is frequently undefined, leading to non-targeted therapy. Viable embryos and placentae express PreImplantation Factor (PIF).

Nonlinear diffusion model for annealed proton-exchanged waveguides in zirconium-doped lithium niobate.

Photorefractive-damage- (PRD) resistant zirconium-oxide-doped lithium niobate is investigated as a substrate for the realization of annealed proton-exchanged (APE) waveguides. Its advantages are a favorable distribution coefficient, PRD resistance comparable to magnesium-oxide-doped lithium niobate, and a proton-diffusion behavior resembling congruent lithium niobate. A 1D model for APE waveguides was developed based on a previous model for congruently melting lithium niobate.

PreImplantation factor (PIF) detection in maternal circulation in early pregnancy correlates with live birth (bovine model).

Background: Early identification of viable pregnancy is paramount for successful reproduction. Detection of specific signals from pre-implantation viable embryos in normal pregnancy circulation would indicate initiation of embryo-maternal interaction and create a continuum to accurately reflect embryo/fetal well-being post-implantation. Viable mammalian embryos secrete PreImplantation Factor (PIF), a biomarker which plays key, multi-targeted roles to promote implantation, trophoblast invasion and modulate maternal innate and adaptive immunity toward acceptance.

Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.

Embryo-secreted preimplantation factor (PIF) is necessary for, and its concentration correlates with, embryo development in humans by promoting implantation and trophoblast invasion. Synthetic PIF (sPIF) modulates systemic immunity and is effective in autoimmune disease models. sPIF binds monocytes and activated T and B cells, leading to immune tolerance without suppression.